Talaga, Patrice
22  Ergebnisse:
Personensuche X
?
4

Open Innovation: share or die…:

Talaga, Patrice
Drug Discovery Today.  14 (2009)  21-22 - p. 1003-1005 , 2009
 
?
6

Alkyne–quinuclidine derivatives as potent and selective mus..:

Starck, Jean-Philippe ; Provins, Laurent ; Christophe, Bernard...
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  8 - p. 2675-2678 , 2008
 
?
7

Potent anti-muscarinic activity in a novel series of quinuc..:

Starck, Jean-Philippe ; Talaga, Patrice ; Quéré, Luc...
Bioorganic & Medicinal Chemistry Letters.  16 (2006)  2 - p. 373-377 , 2006
 
?
9

In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-..:

Fuks, Bruno ; Talaga, Patrice ; Huart, Catherine...
European Journal of Pharmacology.  519 (2005)  1-2 - p. 24-30 , 2005
 
?
10

Inhibitors of beta-amyloid aggregation: still an issue of s..:

Talaga, Patrice
Drug Discovery Today: Therapeutic Strategies.  1 (2004)  1 - p. 7-12 , 2004
 
?
11

Compound decomposition: a new drug discovery tool?:

Talaga, Patrice
Drug Discovery Today.  9 (2004)  2 - p. 51-53 , 2004
 
?
13

Dual NK1 antagonists—serotonin reuptake inhibitors as poten..:

Ryckmans, Thomas ; Berton, Olivier ; Grimée, Renée...
Bioorganic & Medicinal Chemistry Letters.  12 (2002)  21 - p. 3195-3198 , 2002
 
?
14

First dual NK1 antagonists–serotonin reuptake inhibitors: s..:

Ryckmans, Thomas ; Balançon, Laurent ; Berton, Olivier...
Bioorganic & Medicinal Chemistry Letters.  12 (2002)  2 - p. 261-264 , 2002
 
?
15

Pharmacological evaluation of a diarylmethylene-piperidine ..:

Talaga, Patrice ; Matagne, Alain ; Klitgaard, Henrik
Bioorganic & Medicinal Chemistry Letters.  11 (2001)  10 - p. 1313-1316 , 2001
 
1-15